Suppr超能文献

描述危重症患者护理中自愿报告的液体治疗事件:在国家层面识别风险点并从中吸取教训。

Describing voluntarily reported fluid therapy incidents in the care of critically ill patients: Identifying, and learning from, points of risk at the national level.

作者信息

Kurttila Minna, Saano Susanna, Laaksonen Raisa

机构信息

Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland.

KUH Pharmacy, Hospital Pharmacy of Kuopio University Hospital (KUH), Finland.

出版信息

Explor Res Clin Soc Pharm. 2021 Apr 18;2:100012. doi: 10.1016/j.rcsop.2021.100012. eCollection 2021 Jun.

Abstract

BACKGROUND

Fluid therapy is a common intervention in critically ill patients. Fluid therapy errors may cause harm to patients. Thus, understanding of reported fluid therapy incidents is required in order to learn from them and develop protective measures, including utilizing expertise of pharmacists and technology to improve patient safety at the national level.

OBJECTIVES

To describe fluid therapy incidents voluntarily reported in intensive care and high dependency units (ICUs) to a national incident reporting system, by investigating the error types, fluid products, consequences to patients and actions taken to alleviate them, and to identify at which phase of the medication process the incidents had occurred and had been detected.

METHODS

Medication related voluntarily reported incident ( = 7623) reports were obtained from all ICUs in 2007-2017. Incidents concerning fluid therapy ( = 2201) were selected. The retrospective analysis utilized categorized data and narrative descriptions of the incidents. The results were expressed as frequencies and percentages.

RESULTS

Most voluntarily reported incidents had occurred during the ( = 1306, 59%) of the medication process: a point of risk. Most incidents ( = 1975, 90%) had reached the patient and passed through many phases in the medication process and nursing shift change checks before detection. One third of the errors ( = 596, 30%) were reported to have caused consequences to patients. One quarter ( = 492, 25%) of the errors were reported to have required an additional procedure to alleviate or monitor the consequences.

CONCLUSIONS

Utilizing national incident report data enabled identifying systemic points of risk in the medication process and learning to improve patient safety. To prevent similar incidents, initial interventions should focus on the before implementing active medication identification procedures at each phase of the medication process and nursing shift changes. Strengthening clinical pharmacy services, utilizing technology, coordinated by IV Fluid Coordinators and Medication Safety Officers, could improve patient safety in the ICUs.

摘要

背景

液体疗法是危重症患者常见的干预措施。液体疗法错误可能对患者造成伤害。因此,需要了解已报告的液体疗法事件,以便从中吸取教训并制定保护措施,包括利用药剂师的专业知识和技术,在国家层面提高患者安全。

目的

通过调查错误类型、液体产品、对患者的后果以及为减轻后果所采取的措施,描述重症监护病房和高依赖病房(ICU)自愿向国家事件报告系统报告的液体疗法事件,并确定这些事件在用药过程的哪个阶段发生和被发现。

方法

从2007年至2017年所有ICU获取与用药相关的自愿报告事件(n = 7623)报告。选择与液体疗法相关的事件(n = 2201)。回顾性分析利用事件的分类数据和叙述性描述。结果以频率和百分比表示。

结果

大多数自愿报告的事件发生在用药过程的“给药”阶段(n = 1306,59%):这是一个风险点。大多数事件(n = 1975,90%)已影响到患者,并在用药过程和护理班次交接检查的多个阶段中被发现之前就已发生。据报告,三分之一的错误(n = 596,30%)对患者造成了后果。据报告,四分之一的错误(n = 492,25%)需要额外的程序来减轻或监测后果。

结论

利用国家事件报告数据能够识别用药过程中的系统性风险点,并学会提高患者安全。为防止类似事件发生,在用药过程和护理班次交接的每个阶段实施积极的用药识别程序之前,初始干预应集中在“给药”阶段。由静脉输液协调员和用药安全官员协调,加强临床药学服务、利用技术,可以提高ICU患者的安全。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1860/9030324/5d9591e899f8/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验